Susquehanna International Group Ltd. Ice Cure Medical Ltd. Transaction History

Susquehanna International Group Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$0.54 - $1.33 $569 - $1,403	-1,055 Reduced 6.49%	15,200 $8,000
Q2 2023 Aug 11, 2023	BUY	$1.06 - $1.4 $17,230 - $22,757	16,255 New	16,255 $18,000
Q1 2022 May 16, 2022	SELL	$2.01 - $3.31 $25,502 - $41,997	-12,688 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$2.73 - $8.7 $34,638 - $110,385	12,688 New	12,688 $38,000

364K

Ticker ICCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 36,835,600
Market Cap $31.3M
Description
IceCure Medical Ltd, a medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a cryoablation solution for the treatment of breast tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.

Get notified when there are updates to the investment portfolio of Susquehanna International Group Ltd., based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group Ltd. with notifications on news.